HTTIPKV
HTTIPKV is a CAF-selective peptide. HTTIPKV specifically binds to recombinant TAS2R9. HTTIPKV selectively localizes to cancer-associated fibroblasts and the stroma of pancreatic ductal adenocarcinoma. Conjugation of HTTIPKV to liposomes enhances tumor accumulation and improves delivery of encapsulated CXCR2 inhibitors, thereby reducing tumor growth. HTTIPKV can be used for research on pancreatic ductal adenocarcinoma.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C36H62N10O10
- Peso molecular:794.94
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Chemical Information
-
Peso molecular 794.94
-
Fòrmula C36H62N10O10
-
SMILES
O=C(N[C@@H]([C@H](O)C)C(N[C@@H]([C@H](O)C)C(N[C@@H]([C@@H](C)CC)C(N1[C@@H](CCC1)C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(O)=O)=O)=O)=O)=O)=O)[C@H](CC2=CNC=N2)N
-
Sequence
His-Thr-Thr-Ile-Pro-Lys-Val
-
Sequence Shortening
HTTIPKV
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- HTTIPKV
- Biochemical Assay Reagents
- BXPC3/CAF pancreatic ductal adenocarcinoma xenograft
- CXCR2 inhibitor
- GPCR
- TAS2R9
- cancer-associated fibroblast-selective peptide ligand
- cancer-associated fibroblasts
- liposomes
- pancreatic ductal adenocarcinoma
- pancreatic ductal adenocarcinoma stroma
- tumor growth
- Inhibitor
- inhibitor
- inhibit